Abstract
Management of advanced head and neck cancers are often complicated by challenging anatomy, complex reconstructions and long surgical procedures (1). The leading clinical manifestations of patients with ameloblastic carcinomas are large, often painless and rapidly growing mass, swelling, paresthesis, mucosal ulceration, bleeding and tooth mobility (2,3). The tumor may arise from preexistent cysts or develop de novo (2).
This article is protected by copyright. All rights reserved.
http://ift.tt/2xm8lmq
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου